Top medical minds join forces with leading cognitive AI provider to guide artificial intelligence powered innovation for the healthcare industry
“The healthcare industry is eager for AI innovations to help medical professionals care for people,” says AJ Abdallat, Beyond Limits CEO. “With the guidance of our esteemed advisory board, we are ready to contribute advanced technology solutions for this all-important mission.”
Beyond Limits Healthcare Advisory Board
Dr. Wael Barsoum, CEO and President, Cleveland Clinic Florida Region, Cleveland Clinic Board of Governors Member, Fellow of the American Board of Orthopaedic Surgeons and the AAOS.
Dr. Bala Manian, successful Silicon Valley serial entrepreneur, founder of multiple companies including ReaMetrix, Quantum Dot Corp., SurroMed, Biometric Imaging, Lumisys, and Molecular Dynamics.
Dr. Sanjiv Narayan, Professor of Medicine, Stanford University; Cardiologist, Bioengineer, Fellow of the American College of Cardiology. Founder of several medical technology startups. In addition to his MD, Dr. Narayan holds an MSc in Computer Science.
Dr. Manish Kohli, Global Board Chair and Fellow, HIMSS; Former CMIO and Head of Healthcare Informatics, Dubai Health Care City/ University Hospital (Dubai), CMIO, Cleveland Clinic (Abu Dhabi), CMIO, Johns Hopkins Community Physicians (Baltimore); Board Certified – Clinical Informatics, Family Medicine. Member, Standards Advisory Panel, Joint Commission International (JCI)
Dr. Steven Tucker, Preventive Medical Oncologist & Founder of Singapore-based group practice, Tucker Medical; Chief Medical Officer at insurtech start-up, CXA Group; and Director of Oncology & Genomics at MetLife Asia.
Dr. Douglas Johnston, Program Director for Thoracic Surgery, Cleveland Clinic, Committee Member, Society of Thoracic Surgeons, Cleveland Clinic Accountable Care Organization Board Member.
“We are honored to have the benefit of six extremely knowledgeable healthcare industry experts on our team,” says Dr. Manikanda Arunachalam, MD, Beyond Limits Head of Healthcare and SVP Corporate Development & Investments. “This is a world class team that fully understands the power that Beyond Limits cognitive AI can apply to solve difficult healthcare problems.”
Beyond Limits builds cognitive AI systems that interpret vast amounts of data from disparate sources to produce actionable information. For example, historical patient data, lab results, chart notes, real-time sensor monitoring, evidence-based clinical guidelines, and drug interactions, etc., can be interpreted by the system to better understand and personalize treatment suggestions.
Because medical decisions are important and frequently expensive, an AI system must be able to explain its thought process and conclusions. Unlike conventional “black box” approaches like machine learning, deep learning or neural networks that cannot explain their reasoning, Beyond Limits cognitive AI delivers clear explanations of its cognitive reasoning in transparent, evidence-based audit trails, including risk and uncertainties.
Beyond Limits cognitive AI technology combines conventional numeric AI with advanced symbolic logic for human-like reasoning to improve insights, inform decision-making, and reduce risk at the point of care. The company’s technology is considered to be a cognitive leap beyond conventional AI to a human-like ability to perceive, understand, correlate, learn, teach, reason and solve problems faster than existing AI solutions.
Dr. Manikanda Arunachalam Tapped to Lead the Transformation of Life Sciences
Sep 28, 2017, 08:45 ET
GLENDALE, Calif., Sept. 28, 2017 /PRNewswire/ — Beyond Limits (BL), an artificial intelligence (AI) and cognitive computing company, today announced it has appointed Dr. Manikanda Arunachalam, Cardiologist and Venture Capital specialist, as its Senior Vice President for Corporate Development and Investments. Dr. Mani will lead Beyond Limits as it expands and adapts its technology for the healthcare and health tech space, bringing truly cognitive AI solutions to the sector via its Life Sciences platform.
Beyond Limits has appointed Dr. Manikanda Arunachalam, Cardiologist and Venture Capital specialist, as its Senior Vice President for Corporate Development and Investments
“Beyond Limits’ Life Sciences platform provides transformative value proposition to diverse stakeholders in the healthcare industry that could improve clinical outcomes, optimize costs and build sustainable business models,” said Dr. Mani. “Beyond Limits Life Sciences will be an ideal partner for health systems, care plans, CRO’s, genomics companies and many other providers in digital health and healthcare Internet of Things.”
Dr. Mani is a multi-disciplinary professional with expertise in venture capital and private equity, specializing in medical devices, genomics, digital health and healthcare IOT. He is a partner in DS Investments, where he focuses on healthcare technology investments. In addition, he serves on the board of HD Medical Group and is a Strategic Advisor to Guardant Health. Prior to joining Beyond Limits, Dr. Mani served on the Board of Directors at the KEF Company, overseeing its multi-million dollar healthcare investment portfolio. In addition, Dr. Mani has served in key strategic and management roles at Capricorn Healthcare and Special Opportunities Fund, Motherhood India, and Johnson & Johnson Medical Devices.
Dr. Mani began his career as a Cardiologist and was one of the pioneers in conducting multinational clinical trials through his work as an investigator for Eli Lilly, Servier, and Covance. He holds an MD from the prestigious Madras Medical College and an MBA in Finance and Strategy from the Wharton School of The University of Pennsylvania, where he also completed his Fellowship in Cardiology.
AJ Abdallat, CEO of Beyond Limits, said “Beyond Limits’ fast, agile, and cognitive AI technology is an ideal partner for the healthcare industry, where it can be adapted to numerous roles including patient care, data security, and automation of medical devices. With his combined strengths in business development and health technology, as well as strong clinical experience, Dr. Mani is the perfect person to lead our team as we expand into the healthcare space.”
Launched in 2014, Beyond Limits is a leader in AI and cognitive computing and was created to commercialize cutting edge IP developed by the team after over 20 years of success supporting NASA and the space program. With technologies proven in the unknown and extreme environment of space, Beyond Limits adapts and delivers AI software capable of tackling complex industrial and enterprise challenges with the benefits of mechanical automation and human-like reasoning. Beyond Limits recently announced a Series B investment with BP Ventures for $20 million.
About Beyond Limits
Beyond Limits is transforming proven space and defense technologies from NASA and the U.S. Department of Defense into innovative solutions to address large and emerging markets. These technologies were developed at Caltech/Jet Propulsion Laboratory (JPL) over the last two decades and were funded by NASA and the Department of Defense to address their complex and far-reaching problems. Beyond Limits leverages this existing R&D investment along with many of its own technologies to produce commercial products and solutions that are capable of addressing the emerging problems of AI today and beyond. For more information, please visit our website at www.beyond.ai.
Edward M. Yang
1-888-317-4687 (ext. 702)
SOURCE Beyond Limits